Clinical Trials in Colorado

Showing 7881-7900 of 18,143 trials

FX-322 in Adults With Stable Sensorineural Hearing Loss

NCT04120116

This is a phase 2a single and repeat dose exploratory efficacy study of intratympanic FX-322 compared to placebo in healthy male and female adults with stable sensorineural hearing loss.

Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss

Frequency Therapeutics95 participantsStarted Oct 2019

Fresno, California, United States • Torrance, California, United States • Colorado Springs, Colorado, United States +13 more locations

UNKNOWN50 miles

Utilization of High Frequency Ultrasound to Diagnose Chronic Exertional Compartment Syndrome

NCT03736174

The purpose of this study is to investigate high frequency ultrasound as a future modality for the diagnosis of chronic exertional compartment syndrome (CECS). The results of the ultrasound will help determine if there are any significant radiologic findings or patterns seen in patients with CECS.

Chronic Exertional Compartment Syndrome

University of Colorado, Denver20 participantsStarted Dec 2018

Denver, Colorado, United States

FX-322 in Adults With Stable Sensorineural Hearing Loss

Utilization of High Frequency Ultrasound to Diagnose Chronic Exertional Compartment Syndrome

Find Trials by Condition in Colorado

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

A Trial of Neuroprotection With ACTH in Acute Optic Neuritis

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Safety Study of SEA-CD40 in Cancer Patients

Randomized Trial in Adult Participants With Acute Migraines

Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)

A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus

Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

Relative Bioavailability of LY03010 Compared to Listed Drug

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia

Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults